Should a MRSA Nasal Swab Guide Empiric Antibiotic Treatment?

NEJM Evid. 2022 Dec;1(12):EVIDccon2200124. doi: 10.1056/EVIDccon2200124. Epub 2022 Nov 22.

Abstract

MRSA Nasal Swab and Empiric Antibiotic TreatmentMRSA nasal screening has emerged as a potential antimicrobial stewardship tool to guide empiric use of anti-MRSA therapy. The authors address diagnostic considerations when performing MRSA nasal screening and clinical situations in which its results may be used to guide empiric antibiotic therapy in hospitalized patients.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Nose
  • Staphylococcal Infections* / diagnosis

Substances

  • Anti-Bacterial Agents